Your browser doesn't support javascript.
loading
Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor.
Joseph, Nisha S; Tai, Yu-Tzu; Anderson, Kenneth C; Lonial, Sagar.
Afiliación
  • Joseph NS; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
  • Tai YT; Dana-Farber Cancer Institute, Harvard University, Boston, MA, USA.
  • Anderson KC; Dana-Farber Cancer Institute, Harvard University, Boston, MA, USA.
  • Lonial S; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
Clin Pharmacol ; 13: 169-180, 2021.
Article en En | MEDLINE | ID: mdl-34434061
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Clin Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Clin Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos